Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FY 2025 Generic Drugs By The Numbers
Nov 12 2025
•
By
Derrick Gingery
The FDA issued fewer ANDA complete response letters once again in FY 2025.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from United States